Ortho Dermatologics is dedicated to advancing dermatological care through a comprehensive portfolio of FDA-approved treatments designed to address various skin conditions. Their product offerings include a range of topical solutions and medications, such as ALTRENO® (tretinoin) Lotion, Arazlo® (tazarotene) Lotion, and BRYHALI® (halobetasol) Lotion, among others. These products are formulated to provide effective treatment options for patients dealing with issues like acne, psoriasis, and other dermatological concerns. The company emphasizes its commitment to supporting healthcare professionals by providing resources that enhance their ability to deliver quality care.

In addition to their product pipeline, Ortho Dermatologics actively engages in philanthropic efforts, aiming to make a positive impact within the dermatology community and beyond. They focus on connecting with healthcare providers and patients to ensure that the solutions they offer are relevant and beneficial. By empowering dermatology professionals with educational resources and fostering community connections, Ortho Dermatologics strives to improve patient outcomes and support the ongoing development of dermatological practices.

United States

Ortho Dermatologics is one of the largest prescription dermatology businesses dedicated to helping patients in the treatment of a range of therapeutic areas, including psoriasis, actinic keratosis, acne, atopic dermatitis and other dermatoses. The Ortho Dermatologics portfolio includes several leading acne, anti-fungal and corticosteroid-responsive dermatoses products. 

See our community guidelines at https://www.bauschhealth.com/social-media/.

Ortho Dermatologics

Company Details